Analysts at StockNews.com started coverage on shares of Concord Medical Services (NYSE:CCM – Get Free Report) in a note issued to investors on Friday. The firm set a “sell” rating on the stock.
Gracie, a young woman from East Yorkshire, faced a harrowing ordeal when she was diagnosed with a debilitating condition that causes sudden, severe, electric shock-like pain in parts of the face. The ...
Accuray (ARAY) Company Description: Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy ...
The global gamma knife market is on a significant growth trajectory, with market size projections reaching USD 702.5 million by 2033, up from USD 337.7 million in 2023. This robust growth reflects a ...
However, Tibdewal noted that giving them concurrently appears to provide the best outcomes overall. One study demonstrated improved survival when delivering immune checkpoint inhibitors and ...